Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 …
T Nolan, DI Bernstein, SL Block, M Hilty… - …, 2008 - publications.aap.org
OBJECTIVE. This study evaluated the safety, tolerability, and immunogenicity of live
attenuated influenza vaccine administered concurrently with measles-mumps-rubella
vaccine and varicella vaccine to healthy children 12 to 15 months of age. METHODS.
Children were assigned randomly to receive (1) measles-mumps-rubella vaccine, varicella
vaccine, and intranasal placebo on day 0, followed by 1 dose of live attenuated influenza
vaccine on days 42 and 72;(2) measles-mumps-rubella, varicella, and live attenuated …
attenuated influenza vaccine administered concurrently with measles-mumps-rubella
vaccine and varicella vaccine to healthy children 12 to 15 months of age. METHODS.
Children were assigned randomly to receive (1) measles-mumps-rubella vaccine, varicella
vaccine, and intranasal placebo on day 0, followed by 1 dose of live attenuated influenza
vaccine on days 42 and 72;(2) measles-mumps-rubella, varicella, and live attenuated …